For Healthcare Professionals

A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)

clipboard-pencil

About the study

The purpose of this study is to evaluate if TCD601 can induce allogeneic tolerance in living donor renal transplant recipients
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Key Inclusion Criteria:

  1. Able to understand the study requirements and provide written informed consent before any study assessment is performed
  2. Male or female patients ≥ 18 to 65 years of age
  3. Recipient of a renal transplant from a non-human leukocyte antigen (HLA)-identical but at least haploidentical, ABO compatible living donor

EXCLUSION CRITERIA

Key Exclusion Criteria:

  1. Women of child-bearing potential, unless willing to comply with the use of highly effective methods of contraception as defined by the protocol
  2. A history of cancer other than basal cell carcinoma of the skin or carcinoma in situ of the cervix
  3. Recipient with anti-HLA donor-specific antibody (DSA)
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall 347-326-1985Email iconEmail Study Center

Study Details


Contition

Kidney Transplantation

Age

18 - 65

Phase

PHASE2

Participants Needed

18

Est. Completion Date

Mar 31, 2030

Treatment Type

INTERVENTIONAL


Sponsor

ITB-Med LLC

ClinicalTrials.gov NCT Identifier

NCT04803058

Study Number

TCD601A202

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to create a personal profile and 
receive news, resources, and alerts 
about clinical trials related to your conditions of interest.